Showing results (1351-1360 of 1,400) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|October 26, 2023
Plasma Methylated DNA Markers for Melanoma SurveillanceCalise K Berger, William R Taylor, Douglas W Mahoney, et al.
JCO Precision Oncology|July 24, 2023
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient CareAndrea Vingiani, Luca Agnelli, Matteo Duca, et al.
JCO Precision Oncology|July 6, 2023
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor EffectivenessJulia C F Quintanilha, Michael H Storandt, Ryon P Graf, et al.
JCO Precision Oncology|August 10, 2023
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in AdultsJessica Stiefel, Brian H Kushner, Stephen S Roberts, et al.
JCO Precision Oncology|August 25, 2023
Toward Precision Perioperative Therapy in GI MalignanciesMichael J Glover, Jeffrey Bien, Christopher T Chen
JCO Precision Oncology|June 29, 2023
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With CancerElisabeth Wadensten, Sandra Wessman, Frida Abel, et al.
JCO Precision Oncology|June 26, 2023
Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORMAnna-Elisa Heipertz, Kristian W Pajtler, Elke Pfaff, et al.
JCO Precision Oncology|June 5, 2023
Mutation Burden Independently Predicts Survival in the Pan-Cancer AtlasJeffrey R Smith, Fritz F Parl, William D Dupont
JCO Precision Oncology|June 7, 2023
Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck CancerHannah Y Chen, Weilu Zhao, Shorook Na'ara, et al.
JCO Precision Oncology|June 7, 2023
Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced CancerSarah N Gibbs, Desi Peneva, Gebra Cuyun Carter, et al.
Pageof 140